In this issue:
EULAR recommendations for patient research partners in rheumatology research
Evidence-based guidelines for Sjögren’s disease peripheral nervous system symptoms
Persistent physical symptoms: definition, genesis, and management
A symptom-clinic intervention for persistent physical symptoms
Guidelines on diagnostic approach to giant cell arteritis
PDE5 inhibitors for the treatment of severe Raynaud’s phenomenon
Optimising gout treatment: insights from a nurse-led cohort study
Treat-to-target in gout superior to treat-to-avoid symptoms
Oxynorm to continue to be supplied
Minor amendments to Medicare Benefits Schedule
Closure of Orencia Stock Hypercare Plan
Is fatigue a better primary endpoint for RA trials?
The EULAR Network of Trial Centres (ENTRI)
Wearable devices for managing rheumatoid arthritis?
Long-term exposure to air pollution and SLE
Please login below to download this issue (PDF)